Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways

Mani Alikhani, Zoubin Alikhani, Coy Boyd, Christine M. MacLellan, Markos Raptis, Rongkun Liu, Nicole Pischon, Philip C. Trackman, Louis Gerstenfeld, Dana T. Graves

Research output: Contribution to journalArticle

Abstract

We have previously shown that diabetes significantly enhances apoptosis of osteoblastic cells in vivo and that the enhanced apoptosis contributes to diabetes impaired new bone formation. A potential mechanism is enhanced apoptosis stimulated by advanced glycation end products (AGEs). To investigate this further, an advanced glycation product, carboxymethyl lysine modified collagen (CML-collagen), was injected in vivo and stimulated a 5-fold increase in calvarial periosteal cell apoptosis compared to unmodified collagen. It also induced apoptosis in primary cultures of human or neonatal rat osteoblastic cells or MC3T3-E1 cells in vitro. Moreover, the apoptotic effect was largely mediated through RAGE receptor. CML-collagen increased p38 and JNK activity 3.2- and 4.4-fold, respectively. Inhibition of p38 and JNK reduced CML-collagen stimulated apoptosis by 45% and 59% and by 90% when used together (P < 0.05). The predominant apoptotic pathway induced by CML-collagen involved caspase-8 activation of caspase-3 and was independent of NF-κB activation. When osteoblastic cells were exposed to a long-term low dose incubation with CML-collagen, there was a higher degree of apoptosis compared to short-term incubation. In more differentiated osteoblastic cultures, apoptosis was enhanced even further. These results indicate that advanced glycation end products, which accumulate in diabetic and aged individuals, may promote apoptosis of osteoblastic cells and contribute to deficient bone formation.

Original languageEnglish (US)
Pages (from-to)345-353
Number of pages9
JournalBone
Volume40
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Advanced Glycosylation End Products
Osteoblasts
Phosphotransferases
Apoptosis
Collagen
Osteogenesis
Caspase 8
Caspase 3
N(6)-carboxymethyllysine

Keywords

  • AGE
  • Apoptosis
  • Bone
  • Cell death
  • Diabetes
  • Hyperglycemia

ASJC Scopus subject areas

  • Physiology
  • Hematology

Cite this

Alikhani, M., Alikhani, Z., Boyd, C., MacLellan, C. M., Raptis, M., Liu, R., ... Graves, D. T. (2007). Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone, 40(2), 345-353. https://doi.org/10.1016/j.bone.2006.09.011

Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. / Alikhani, Mani; Alikhani, Zoubin; Boyd, Coy; MacLellan, Christine M.; Raptis, Markos; Liu, Rongkun; Pischon, Nicole; Trackman, Philip C.; Gerstenfeld, Louis; Graves, Dana T.

In: Bone, Vol. 40, No. 2, 02.2007, p. 345-353.

Research output: Contribution to journalArticle

Alikhani, M, Alikhani, Z, Boyd, C, MacLellan, CM, Raptis, M, Liu, R, Pischon, N, Trackman, PC, Gerstenfeld, L & Graves, DT 2007, 'Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways', Bone, vol. 40, no. 2, pp. 345-353. https://doi.org/10.1016/j.bone.2006.09.011
Alikhani, Mani ; Alikhani, Zoubin ; Boyd, Coy ; MacLellan, Christine M. ; Raptis, Markos ; Liu, Rongkun ; Pischon, Nicole ; Trackman, Philip C. ; Gerstenfeld, Louis ; Graves, Dana T. / Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. In: Bone. 2007 ; Vol. 40, No. 2. pp. 345-353.
@article{35353cfd92fb4b50abefaee58a4b9ded,
title = "Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways",
abstract = "We have previously shown that diabetes significantly enhances apoptosis of osteoblastic cells in vivo and that the enhanced apoptosis contributes to diabetes impaired new bone formation. A potential mechanism is enhanced apoptosis stimulated by advanced glycation end products (AGEs). To investigate this further, an advanced glycation product, carboxymethyl lysine modified collagen (CML-collagen), was injected in vivo and stimulated a 5-fold increase in calvarial periosteal cell apoptosis compared to unmodified collagen. It also induced apoptosis in primary cultures of human or neonatal rat osteoblastic cells or MC3T3-E1 cells in vitro. Moreover, the apoptotic effect was largely mediated through RAGE receptor. CML-collagen increased p38 and JNK activity 3.2- and 4.4-fold, respectively. Inhibition of p38 and JNK reduced CML-collagen stimulated apoptosis by 45{\%} and 59{\%} and by 90{\%} when used together (P < 0.05). The predominant apoptotic pathway induced by CML-collagen involved caspase-8 activation of caspase-3 and was independent of NF-κB activation. When osteoblastic cells were exposed to a long-term low dose incubation with CML-collagen, there was a higher degree of apoptosis compared to short-term incubation. In more differentiated osteoblastic cultures, apoptosis was enhanced even further. These results indicate that advanced glycation end products, which accumulate in diabetic and aged individuals, may promote apoptosis of osteoblastic cells and contribute to deficient bone formation.",
keywords = "AGE, Apoptosis, Bone, Cell death, Diabetes, Hyperglycemia",
author = "Mani Alikhani and Zoubin Alikhani and Coy Boyd and MacLellan, {Christine M.} and Markos Raptis and Rongkun Liu and Nicole Pischon and Trackman, {Philip C.} and Louis Gerstenfeld and Graves, {Dana T.}",
year = "2007",
month = "2",
doi = "10.1016/j.bone.2006.09.011",
language = "English (US)",
volume = "40",
pages = "345--353",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways

AU - Alikhani, Mani

AU - Alikhani, Zoubin

AU - Boyd, Coy

AU - MacLellan, Christine M.

AU - Raptis, Markos

AU - Liu, Rongkun

AU - Pischon, Nicole

AU - Trackman, Philip C.

AU - Gerstenfeld, Louis

AU - Graves, Dana T.

PY - 2007/2

Y1 - 2007/2

N2 - We have previously shown that diabetes significantly enhances apoptosis of osteoblastic cells in vivo and that the enhanced apoptosis contributes to diabetes impaired new bone formation. A potential mechanism is enhanced apoptosis stimulated by advanced glycation end products (AGEs). To investigate this further, an advanced glycation product, carboxymethyl lysine modified collagen (CML-collagen), was injected in vivo and stimulated a 5-fold increase in calvarial periosteal cell apoptosis compared to unmodified collagen. It also induced apoptosis in primary cultures of human or neonatal rat osteoblastic cells or MC3T3-E1 cells in vitro. Moreover, the apoptotic effect was largely mediated through RAGE receptor. CML-collagen increased p38 and JNK activity 3.2- and 4.4-fold, respectively. Inhibition of p38 and JNK reduced CML-collagen stimulated apoptosis by 45% and 59% and by 90% when used together (P < 0.05). The predominant apoptotic pathway induced by CML-collagen involved caspase-8 activation of caspase-3 and was independent of NF-κB activation. When osteoblastic cells were exposed to a long-term low dose incubation with CML-collagen, there was a higher degree of apoptosis compared to short-term incubation. In more differentiated osteoblastic cultures, apoptosis was enhanced even further. These results indicate that advanced glycation end products, which accumulate in diabetic and aged individuals, may promote apoptosis of osteoblastic cells and contribute to deficient bone formation.

AB - We have previously shown that diabetes significantly enhances apoptosis of osteoblastic cells in vivo and that the enhanced apoptosis contributes to diabetes impaired new bone formation. A potential mechanism is enhanced apoptosis stimulated by advanced glycation end products (AGEs). To investigate this further, an advanced glycation product, carboxymethyl lysine modified collagen (CML-collagen), was injected in vivo and stimulated a 5-fold increase in calvarial periosteal cell apoptosis compared to unmodified collagen. It also induced apoptosis in primary cultures of human or neonatal rat osteoblastic cells or MC3T3-E1 cells in vitro. Moreover, the apoptotic effect was largely mediated through RAGE receptor. CML-collagen increased p38 and JNK activity 3.2- and 4.4-fold, respectively. Inhibition of p38 and JNK reduced CML-collagen stimulated apoptosis by 45% and 59% and by 90% when used together (P < 0.05). The predominant apoptotic pathway induced by CML-collagen involved caspase-8 activation of caspase-3 and was independent of NF-κB activation. When osteoblastic cells were exposed to a long-term low dose incubation with CML-collagen, there was a higher degree of apoptosis compared to short-term incubation. In more differentiated osteoblastic cultures, apoptosis was enhanced even further. These results indicate that advanced glycation end products, which accumulate in diabetic and aged individuals, may promote apoptosis of osteoblastic cells and contribute to deficient bone formation.

KW - AGE

KW - Apoptosis

KW - Bone

KW - Cell death

KW - Diabetes

KW - Hyperglycemia

UR - http://www.scopus.com/inward/record.url?scp=33846010477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846010477&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2006.09.011

DO - 10.1016/j.bone.2006.09.011

M3 - Article

VL - 40

SP - 345

EP - 353

JO - Bone

JF - Bone

SN - 8756-3282

IS - 2

ER -